<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Worldwide Healthcare Trust Plc — News on 6ix</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc</link>
<description>Latest news and press releases for Worldwide Healthcare Trust Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 13 Apr 2026 14:20:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/worldwide-healthcare-trust-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835ee9078dffbe2df12c108.webp</url>
<title>Worldwide Healthcare Trust Plc</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc</link>
</image>
<item>
<title>Monthly Fact Sheet as at 31 March 2026</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-march-2026-2</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-march-2026-2</guid>
<pubDate>Mon, 13 Apr 2026 14:20:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has announced that its monthly fact sheet as at 31 March 2026 will soon be available on the company's website, www.worldwidewh.com. This update provides investors with the latest financial data and performance metrics for the trust.
Disclaimer*</description>
</item>
<item>
<title>Biogen, Inc. to acquire WWH portfolio company...</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/biogen-inc-to-acquire-wwh-portfolio-company</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/biogen-inc-to-acquire-wwh-portfolio-company</guid>
<pubDate>Wed, 01 Apr 2026 15:36:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC notes Biogen Inc.'s agreement to acquire its portfolio company, Apellis Pharmaceuticals, Inc., for approximately $5.6 billion, or $41 per share in cash, representing a 140% premium. This offer includes an additional $4 per share in contingent value rights, potentially increasing the premium to 163% if sales milestones are met. Apellis, a biopharmaceutical company with two approved C3-targeted drugs, EMPAVELI and SYFOVRE, generated $689 million in net product revenu</description>
</item>
<item>
<title>Net Asset Value(s)</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/net-asset-values-53</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/net-asset-values-53</guid>
<pubDate>Fri, 27 Mar 2026 13:36:00 GMT</pubDate>
<description>Net Asset Value(s).</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/transaction-in-own-shares-571</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/transaction-in-own-shares-571</guid>
<pubDate>Fri, 20 Mar 2026 17:35:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has purchased 400,000 of its own ordinary shares at 333.68 pence per share, utilizing its authority to buy back up to 61,086,622 shares. Following this transaction, the company now holds 227,872,783 shares in treasury, with a total of 601,665,200 ordinary shares in issue. The total number of voting rights in the company is now 373,792,417, which shareholders should use as the denominator for calculating notification requirements under the FCA's Disclosure Guidance </description>
</item>
<item>
<title>Monthly Fact Sheet as at 28 February 2026</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-28-february-2026</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-28-february-2026</guid>
<pubDate>Thu, 12 Mar 2026 09:29:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has announced that its monthly fact sheet as at 28 February 2026 will soon be available on the company's website, www.worldwidewh.com. This update provides investors with the latest performance data and key financial figures for the trust.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/total-voting-rights-284</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/total-voting-rights-284</guid>
<pubDate>Mon, 02 Mar 2026 08:26:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has announced its total voting rights as of 28 February 2026. The company's capital comprises 601,665,200 ordinary shares, each with one voting right, though 223,722,783 shares are held in treasury. Consequently, the total number of voting rights available to shareholders is 377,942,417, which shareholders should use as the denominator for calculating notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Monthly Fact Sheet as at 31 January 2026</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-january-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-january-2026-1</guid>
<pubDate>Thu, 12 Feb 2026 14:37:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has announced that its monthly fact sheet as at 31 January 2026 will be available on the company's website, www.worldwidewh.com. This update provides shareholders with the latest financial information regarding the company's performance.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/directorpdmr-shareholding-719</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/directorpdmr-shareholding-719</guid>
<pubDate>Tue, 20 Jan 2026 16:42:00 GMT</pubDate>
<description>Timothy James Livett, a Non-executive Director of Worldwide Healthcare Trust PLC, has made an initial notification regarding a dividend reinvestment transaction. On 9 January 2026, 39 ordinary 2.5p shares were acquired on the London Stock Exchange at a price of 388.698 pence per share. This transaction represents an investment of £151.59 in the company.
Disclaimer*</description>
</item>
<item>
<title>Monthly Fact Sheet as at 31 December 2025</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-december-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-december-2025-2</guid>
<pubDate>Fri, 16 Jan 2026 12:07:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has announced that its monthly fact sheet as at 31 December 2025 will soon be available on the company's website, www.worldwidewh.com. This update provides investors with the latest financial data and performance metrics for the trust.
Disclaimer*</description>
</item>
<item>
<title>Correction-Transaction in Own Shares</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/correction-transaction-in-own-shares-9</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/correction-transaction-in-own-shares-9</guid>
<pubDate>Thu, 08 Jan 2026 12:03:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has corrected its previous announcement regarding a transaction in its own shares, stating that it now holds 214,334,345 Ordinary shares in treasury following the purchase of 501,277 shares at 376.51 pence each. The total number of Ordinary shares with voting rights in the Company is now 387,330,855, which shareholders should use as the denominator for calculating their interests under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer</description>
</item>
<item>
<title>Monthly Fact Sheet as at 30 November 2025</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-30-november-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-30-november-2025-2</guid>
<pubDate>Tue, 09 Dec 2025 10:58:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has released its monthly fact sheet as of 30 November 2025, which is now available for inspection on the company's website. This update provides key financial data and performance metrics relevant to investors.
Disclaimer*</description>
</item>
<item>
<title>Edison issues report on Worldwide Healthcare ...</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/edison-issues-report-on-worldwide-healthcare</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/edison-issues-report-on-worldwide-healthcare</guid>
<pubDate>Wed, 03 Dec 2025 07:55:00 GMT</pubDate>
<description>Worldwide Healthcare Trust (WWH) reported a strong first half of fiscal year 2026, with net asset value and share price total returns of +5.0% and +10.9% respectively, significantly outperforming the benchmark's -5.3% return. This performance, the trust's best in a decade, is attributed to a focus on innovation and growth in emerging biotech and Chinese stocks. Since its inception in April 1995, WWH has achieved average annual NAV total returns of +13.4%, exceeding the benchmark's +10.9%. The re</description>
</item>
<item>
<title>Update statement regarding the re-election of...</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/update-statement-regarding-the-re-election-of</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/update-statement-regarding-the-re-election-of</guid>
<pubDate>Fri, 28 Nov 2025 16:21:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC reported that while all resolutions passed at its AGM, over 20% of votes were cast against the re-election of Directors Doug McCutcheon and Sven Borho. Shareholders cited Mr. McCutcheon's 12-year tenure and Mr. Borho's role as Managing Partner at the Company's Portfolio Manager, OrbiMed Capital LLC, as reasons for their opposition. The Board defended Mr. McCutcheon's continued service as Chair until his planned retirement in July 2026, emphasizing his role in board</description>
</item>
<item>
<title>Monthly Fact Sheet as at 31 October 2025</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-october-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-31-october-2025-2</guid>
<pubDate>Thu, 13 Nov 2025 10:12:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has released its monthly fact sheet as of 31 October 2025, which has been submitted to the London Stock Exchange and will be available on the company's website.
Disclaimer*</description>
</item>
<item>
<title>Half-year Financial Report</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/half-year-financial-report-64</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/half-year-financial-report-64</guid>
<pubDate>Thu, 13 Nov 2025 07:00:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC reported a net asset value (NAV) per share total return of +5.0% and a share price total return of +10.9% for the six months ended 30 September 2025, significantly outperforming its benchmark. The company's NAV per share increased to 354.4p from 339.5p, while the share price rose to 328.0p from 297.5p, narrowing the discount to NAV from 12.4% to 7.4%. Leverage increased to 16.4% from 12.0%, and ongoing charges remained at 0.9%. The company repurchased 87,115,980 sh</description>
</item>
<item>
<title>Chair Succession</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/chair-succession-9</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/chair-succession-9</guid>
<pubDate>Thu, 06 Nov 2025 07:00:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC announced its planned Chair succession, with Doug McCutcheon retiring from the Board at the Annual General Meeting on Tuesday, 14 July 2026. William Hemmings, who joined the Board on 1 October 2024, will succeed him as Chair. Mr. Hemmings brings extensive experience from the investment trust sector, having previously served as Head of Closed End Funds and Head of Investment Companies at Aberdeen Group, and as a non-executive Director at Primary Health Properties Pl</description>
</item>
<item>
<title>Interim Dividend</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/interim-dividend-15</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/interim-dividend-15</guid>
<pubDate>Wed, 05 Nov 2025 17:37:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC has declared an unchanged interim dividend of 0.7 pence per share for the year ending 31 March 2026. This dividend is scheduled for payment on 9 January 2026 to shareholders on the register by 28 November 2025, with the associated ex-dividend date being 27 November 2025. A final dividend for the same financial year will be proposed to shareholders at the Company's Annual General Meeting in July 2026. Shareholders interested in the Dividend Reinvestment Plan must el</description>
</item>
<item>
<title>Compliance with Market Abuse Regulation</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/compliance-with-market-abuse-regulation-27</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/compliance-with-market-abuse-regulation-27</guid>
<pubDate>Mon, 13 Oct 2025 08:35:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC confirms compliance with the Market Abuse Regulation, stating that all inside information has been disclosed. The company's net asset value per share is calculated and announced daily. Furthermore, the company anticipates no material difference between the net asset value per share as of September 30, 2025, already announced on October 1, 2025, and the upcoming results for the half year ended September 30, 2025. Consequently, the company is permitted to trade in it</description>
</item>
<item>
<title>Monthly Fact Sheet as at 30 September 2025</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-30-september-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/monthly-fact-sheet-as-at-30-september-2025-2</guid>
<pubDate>Fri, 10 Oct 2025 08:57:00 GMT</pubDate>
<description>Worldwide Healthcare Trust PLC released its monthly fact sheet as of September 30, 2025. The document has been submitted to the London Stock Exchange and will soon be accessible for review on the company's website at www.worldwidewh.com.
Disclaimer*</description>
</item>
<item>
<title>Result of General Meeting and renewal of shar...</title>
<link>https://6ix.com/company/worldwide-healthcare-trust-plc/news/result-of-general-meeting-and-renewal-of-shar</link>
<guid isPermaLink="true">https://6ix.com/company/worldwide-healthcare-trust-plc/news/result-of-general-meeting-and-renewal-of-shar</guid>
<pubDate>Wed, 01 Oct 2025 10:25:00 GMT</pubDate>
<description>At the General Meeting of Worldwide Healthcare Trust PLC held on October 1, 2025, shareholders approved the renewal of the company's authority to make market purchases of ordinary shares of 2.5 pence each. The special resolution for the repurchase of shares received 182,494,356 votes in favor, representing 96.96% of the votes cast, while 5,718,960 votes were against, representing 3.04%. Total votes cast amounted to 188,213,316, which is 46.19% of the issued share capital with voting rights. Ther</description>
</item>
</channel>
</rss>